Anti-metastatic potential of somatostatin analog SOM230: Indirect pharmacological targeting of pancreatic cancer-associated fibroblasts. - Wikidata - wikimedia - TriplyDB

Anti-metastatic potential of somatostatin analog SOM230: Indirect pharmacological targeting of pancreatic cancer-associated fibroblasts.

Anti-metastatic potential of somatostatin analog SOM230: Indirect pharmacological targeting of pancreatic cancer-associated fibroblasts.

http://www.wikidata.org/entity/Q37520300

about

Chemotherapy and tumor microenvironment of pancreatic cancer.The Emerging Roles of Extracellular Vesicles As Communication Vehicles within the Tumor Microenvironment and Beyond.Pasireotide is more effective than octreotide, alone or combined with everolimus on human meningioma in vitro Does pasireotide directly modulate skeletal muscle metabolism?Interferon-γ and Colorectal Cancer: an up-to date.Octreotide Does Not Inhibit Proliferation in Five Neuroendocrine Tumor Cell Lines.International Union of Basic and Clinical Pharmacology. CV. Somatostatin Receptors: Structure, Function, Ligands, and New Nomenclature

P2860

Q33876637-B6CB88EF-382E-4524-9175-5ED6C4E13030 Q38636468-8D836604-3883-4E98-A6F0-B54922C37D37 Q41548629-DAFE0B9D-F253-4C22-B8C0-D327EBF8528F Q48307756-3F3FA490-51C1-498C-9092-E6C214096736 Q49199768-9C628D9B-46F0-4340-BACB-9C5659BE536A Q52717640-7D6DBE04-AD9D-4E08-84EA-532F3A074FD0 Q57144951-0E5A32CA-CEA4-496C-8BCC-892718828C9A

P2860

Anti-metastatic potential of somatostatin analog SOM230: Indirect pharmacological targeting of pancreatic cancer-associated fibroblasts.

http://www.wikidata.org/entity/Q37520300

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 12 May 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Anti-metastatic potential of s ...... cancer-associated fibroblasts.

@en

Anti-metastatic potential of s ...... cancer-associated fibroblasts.

@nl

type

label

Anti-metastatic potential of s ...... cancer-associated fibroblasts.

@en

Anti-metastatic potential of s ...... cancer-associated fibroblasts.

@nl

prefLabel

Anti-metastatic potential of s ...... cancer-associated fibroblasts.

@en

Anti-metastatic potential of s ...... cancer-associated fibroblasts.

@nl

P1433

Q37520300-4020100B-9765-4E9F-82E8-41088A784696

P1476

Q37520300-0F1AE558-BC7C-4875-93EB-7F354E9865CD

P2093

Q37520300-04D2CBA0-37F1-46A3-B7BF-FBDBCBD8DC2E

Q37520300-07F7A488-E9CA-4B2F-9F5C-E2C29AF84D54

Q37520300-152C0E42-0B4A-42C0-A55D-EFEBA3403103

Q37520300-3E6CEE1F-101F-432D-81AB-17077E62B077

Q37520300-576CB623-EE30-488A-8DF5-A05FC9837C38

Q37520300-700081CC-F171-45AF-A588-3DE0E6E4AD90

Q37520300-8FECDB07-2670-4840-BCD8-4732A2CAA8F6

Q37520300-AD59CA07-CE31-49E2-BAAE-82F550B1CE21

Q37520300-ADA18EFC-5462-46ED-8B41-840BFDEF07F6

Q37520300-B32B59E7-06EA-476E-93A3-1272E0848026

P2860

Q37520300-00B17195-828B-4A39-91FA-C4F7EDC8362B

Q37520300-02C15D47-99CF-4C99-933C-DB0CEE7F4CBC

Q37520300-054B3FDF-1452-4D0D-9823-C4497711DDC2

Q37520300-16882E18-3C12-49A6-9290-92640DBE180C

Q37520300-271E7627-F370-4995-BA6B-80C4201312EF

Q37520300-2A279B88-63B3-41AD-8F76-DE05BD7AFB1B

Q37520300-2B30C366-3DEB-4574-BCFB-30D12ED924C0

Q37520300-2F1C0C68-0F87-4D88-AF40-57DFC1BCEF0A

Q37520300-31C265BE-5FC4-4C83-85CC-F8396E77E3BE

Q37520300-3C5636E5-478C-4DB1-B18F-D976FF4DD59D

P304

Q37520300-D5B04976-B27D-4128-B139-123A01E639BB

P31

Q37520300-03F15012-40E6-489D-93C8-A7C37B6DC0E0

P356

Q37520300-07E2864B-D367-4674-BFFB-AD6949C9E767

P407

Q37520300-5C5012B5-B5FA-43C9-ADCE-E93E89F04FD2

P433

Q37520300-926A1002-5E90-461B-81EC-A4BB8E4A4E8F

P478

Q37520300-8C4FD037-B57C-4ADB-A2CE-ECC952D1CD06

P50

Q37520300-0EF6BB1C-AD02-413B-A691-4252E4E3D8D4

P577

Q37520300-2A87F8C5-5550-4880-9CD2-9673089A7ACC

P698

Q37520300-195C9762-8695-4F2C-A56F-7174F2CFF651

P921

Q37520300-7020B25F-ABE8-477B-B51A-16353B2F7772

P932

Q37520300-4BA875A6-ED23-4C06-87D1-31E4F5212D0F

P356

ONCOTARGET.9296

P1433

P1476

Anti-metastatic potential of s ...... cancer-associated fibroblasts.

@en

P2093

Aurélie Perraud

http://www.w3.org/2001/XMLSchema#string

Camille Duluc

http://www.w3.org/2001/XMLSchema#string

Corinne Bousquet

http://www.w3.org/2001/XMLSchema#string

Emilie Decaup

http://www.w3.org/2001/XMLSchema#string

Herbert Schmid

http://www.w3.org/2001/XMLSchema#string

Janick Selves

http://www.w3.org/2001/XMLSchema#string

Muriel Mathonnet

http://www.w3.org/2001/XMLSchema#string

Rémi Samain

http://www.w3.org/2001/XMLSchema#string

Siham Moatassim-Billah

http://www.w3.org/2001/XMLSchema#string

Stéphane Pyronnet

http://www.w3.org/2001/XMLSchema#string

P2860

The Hallmarks of Cancer

Direct binding of p85 to sst2 somatostatin receptor reveals a novel mechanism for inhibiting PI3K pathway

Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes

Fibroblasts in cancer

Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion

The transcription factor GLI1 modulates the inflammatory response during pancreatic tissue remodeling

Co-delivery of doxorubicin and siRNA using octreotide-conjugated gold nanorods for targeted neuroendocrine cancer therapy.

StellaTUM: current consensus and discussion on pancreatic stellate cell research.

Pharmacological targeting of the protein synthesis mTOR/4E-BP1 pathway in cancer-associated fibroblasts abrogates pancreatic tumour chemoresistance.

A switch of G protein-coupled receptor binding preference from phosphoinositide 3-kinase (PI3K)-p85 to filamin A negatively controls the PI3K pathway.

P304

41584-41598

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.9296

http://www.w3.org/2001/XMLSchema#string

P407

P433

27

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-05-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27177087

http://www.w3.org/2001/XMLSchema#string

P921

P932

5173080

http://www.w3.org/2001/XMLSchema#string